Pictet Asset Management
MRVI icon

Pictet Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Pictet Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,855
Closed -$24K – 2038
2025
Q1 		$24K Hold
10,855
– – ﹤0.01% 2004
2024
Q4 		$59.2K Hold
10,855
– – ﹤0.01% 2012
2024
Q3 		$90.2K Hold
10,855
– – ﹤0.01% 1951
2024
Q2 		$77.7K Hold
10,855
– – ﹤0.01% 1915
2024
Q1 		$94.1K Hold
10,855
– – ﹤0.01% 1893
2023
Q4 		$71.1K Hold
10,855
– – ﹤0.01% 1909
2023
Q3 		$109K Buy
+10,855
New +$119K ﹤0.01% 1819

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pictet Asset Management's MRVI Position: Q2 2025 in Review

Pictet Asset Management sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 10,855 shares — an estimated $24K sold.

Pictet Asset Management first reported a position in MRVI in Q3 2023 and held it in 7 quarters. The position peaked at $109K in Q3 2023. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Pictet Asset Management reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Pictet Asset Management sold 10,855 Maravai LifeSciences shares in Q2 2025, an estimated $24K.
  • Pictet Asset Management first reported a position in Maravai LifeSciences in Q3 2023 and held it in 7 quarters.
  • Pictet Asset Management's Maravai LifeSciences position peaked at $109K in Q3 2023.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Pictet Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.